Basta Steven L Insider Trades

Insider Trading History

Track insider trading activity for Basta Steven L. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $3.74M 379,592 shares
Last Trade
Feb 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$158k 12,362 shares
$12.82
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $3.68M 373,315 shares
Last Trade
Feb 10, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$80.5k 6,277 shares
$12.82
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $3.6M 364,820 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.5M 477,190 shares
$15.71
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $1.43M 145,288 shares
Last Trade
Dec 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$953k 62,038 shares
$15.36
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $1.12M 113,786 shares
Last Trade
Dec 17, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$484k 31,502 shares
$15.36
$9.86
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.6k 20,000 shares
$0.38
$0.67
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $1.3M 131,625 shares
Last Trade
Nov 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.41M 90,000 shares
$15.62
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $1.77M 180,000 shares
Last Trade
Nov 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.41M 90,000 shares
$15.62
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $821k 83,250 shares
Last Trade
Nov 28, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$756k 48,375 shares
$15.62
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $2.66M 270,000 shares
Last Trade
Sep 25, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 90,000 shares
$11.66
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $887k 90,000 shares
Last Trade
Sep 25, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 90,000 shares
$11.66
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $410k 41,625 shares
Last Trade
Sep 25, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$564k 48,375 shares
$11.66
$9.86
Phathom Pharmaceuticals
Phathom Pharmaceuticals PHAT
President And CEO
Holding Value $10.7M 1,085,000 shares
Last Trade
Apr 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.44M 1,085,000 shares
$5.01
$9.86
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48k 20,000 shares
$2.40
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Jan 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.6k 20,000 shares
$2.33
$0.67
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.3k 20,000 shares
Last Trade
Dec 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54k 20,000 shares
$2.70
$0.67
Viveve Medical
Viveve Medical VIVE
Director
Holding Value $14.4 72,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.8k 72,000 shares
$0.65
$0.00
VYNE Therapeutics
VYNE Therapeutics VYNE
Director
Holding Value $13.6k 20,500 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.4k 20,500 shares
$0.31
$0.67
Menlo Therapeutics
Menlo Therapeutics MNLO
Director
Holding Value $0 20,500 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Viveve Medical
Viveve Medical VIVE
Director
Holding Value $9.6 48,000 shares
Last Trade
Jan 04, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$60.5k 48,000 shares
$1.26
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up